Immunoglobulin G (IgG) antibodies to carcinoembryonic antigen (CEA) were labelled with radioactive indium
Introduction
There is considerable interest in the localisation of tumours using radiolabelled antibodies. Tumours of the gastrointestinal tract,' thyroid,2 germ cell tissue,3 and insulinomas5 have been detected using various different antibodies. In most reports iodine-131 (1311) has been used as the radiolabel, but it is not ideal because the high energy gamma ray is poorly detected and the emission of 3-contributes to a high radiation dose. 123J has been tried6 but has a short half life (13 hours) and cannot be used in a dual isotope procedure with technetium-99m (9 9mTc) for background subtraction. Two further problems with iodine isotopes are that they are not retained in cells and iodination of proteins is too time consuming for a nuclear medicine department.
Indium-111 ("'In) has been suggested7 as an alternative radiolabel for the following reasons: (a) the gamma energies (171 and 247 keV) are better detected by conventional gammacameras; (b) the half life (2-83 days) is more suitable for antibody imaging; (c) it is known to be chemically stable within cells8; and (d) protein labelling can be conveniently and simply carried out using a bifunctional chelating agent. 9 Disadvantages of using "'In are, firstly, that the available isotope has a lower effective specific activity than iodine and, secondly, that it is complex to prepare chelate linked proteins with enough groups available to bind "'In in large amounts. A chelate that has been used for "'In binding is diethylenetriamine-penta-acetic acid (DTPA), which has been successfully linked to albumin'0 for use as a blood pool reagent and to anti-myosin" for imaging canine myocardium. Recently a monoclonal antibody to carcinoembryonic antigen (CEA) radiolabelled with "'In via DTPA has been shown successfully to localise to human tumours transplanted into nude mice."
We describe the preparation and labelling of an antiserum to CEA with "'In to high specific activity and its use for locating tumours in 11 patients. Five of the patients were also scanned using the same antibody labelled with 131I.
Methods and patients ANTISERUM Polyclonal antiserum to CEA was prepared in sheep by immunising with CEA extracted from hepatic metastases of a colonic carcinoma. Non-specific antibodies were adsorbed on glutaraldehyde polymers of 16 JULY 1983 167 human serum and normal tissues until a specific reaction was obtained on colorectal carcinoma tissue sections using the peroxidase antiperoxidase technique. A fraction of the antiserum rich in immunoglobulin G (IgG) was prepared by ion exchange chromatography on diethylaminoethyl (DEAE) 52 cellulose, then sterilised by filtration and tested for pyrogens by an independent laboratory. Both before and after radiolabelling, the titre of the antibody was tested by reverse radial immunodiffusion. Affinity was assessed by a double antibody radioimmunoassay using 12I1 labelled CEA. 13 and subtraction was necessary to enhance the image. In contrast, "'In gave a clear, positive scan five days after injection (fig 1 (c) ), and at nine days the tumour was still visible without subtraction. Table II gives the ratios of tumour to normal tissue for these scans, and even when these ratios were equal (day 1) the "'In scan was visually superior, as assessed by the count rate per pixel in the tumour ( 
DISTRIBUTION AND DOSIMETRY OF LABELLED ANTIBODIES
In the first 24 hours after injection 330, (range 24°o to 460 ) of the injected 131I activity was recovered in the urine and in the second 24 hours 200, (range 13°, to 280) was recovered. With "'In labelled antibodies l0/, (range 4-3O' to 15°,) of the injected activity was recovered in the urine in the first 24 hours and 300 daily thereafter (up to seven days).
In patients given oral iodide and perchlorate neither 13'I nor 99mTc accumulated in any organ except the bladder. In contrast, 200, of the injected dose of "'In accumulated in the liver and remained there for the duration of the study (eight days). This was the only organ significantly to accumulate "'In, and in particular there was little activity in the skeleton.
Whole body doses were the same for both isotopes, about 0 135 mSv (13 5 
Discussion
These results show that "'In-anti-CEA detected more tumour sites and with greater certainty than did 131I-anti-CEA. Overall sensitivity of the 131I scans (530o) was lower than in some reports,' 2but this varies with the criteria used for staging. Furthermore, different groups ofpatients may not be comparable, and in our study comparisons were made within patients using the same dose of each isotope. The amount of isotope injected, however, was lower than used by some workers.' One patient received 66 MBq (1 8 mCi) but the others received between 18 5 and 27 7 MBq (0 5-0 75 mCi). Improved sensitivity was not shown simply by the excess of positive sites with "'In, but when lesions were detected by both isotopes "'In had more + + scores, and when individual scans were compared the "'In counts reached higher statistical significance.
This improvement may largely be related to improved count rates. There was some improvement in ratios of tumour to normal tissue, which may reflect different in vivo handling of the two isotopes. Nevertheless, a clear distinction must be made between increased label in the tumour and a reduction in blood pool activity. Our results suggest that most accumulation occurs in the first 48 hours; but the label remains there, and further improvements in ratios are the result of blood clearance (see half life corrected figures in table II). This is in contrast with 131J, which is less stable in tumours, presumably due to internalisation and deiodination."1 On cursory inspection "'In might be thought to offer a great advantage over "3'I in terms of dosimetry because of the absence of energetic 3-particles. "'In, however, produces several low energy x rays and electrons which, combined with its longer biological half life, offset this advantage. Critical organ dose from "'In was to the liver, and from 1311 to the bladder. We emphasise that the dosimetry calculation was based on a small excretion of "'In but a large excretion of 131I. Since individual patients may vary widely in their rate of iodine excretion some may receive a higher dose from "3'I than that calculated. In addition, it is important to ensure adequate blockade of the thyroid and stomach with iodide and perchlorate.
The doses used in our study were cautious, and the British Institute of Radiology guidelines"8 would allow 300 MBq (81 mCi) of either isotope to be administered to such patients for clinical indications (50 mSv (5 rem) whole body and 250 mSv single organ). Radiation dose with computed tomography is about 10 mSv (1 rem) per examination, and some other x ray techniques, especially fluorography, give comparable doses.
With regard to detector efficiency and spatial resolution, our high energy collimator has an efficiency of 630o compared with the medium energy collimator.'9 When counting only the 247 keV "'In peak there is a detector efficiency factor of 3 2 in favour of "'In, reducing to 2 3 after 48 hours; if both "'In peaks are included the factors are 7 8 and 5-6 respectively. Spatial resolution at 10 cm from the collimator face is 20 mm full width half maximum for 131J and 17 mm full width half maximum for "'1In."9 With regard to the antiserum, the total binding sites were not affected by either labelling procedure, but incorporating up to five molecules of DTPA had a measurable effect on affinity profile. The substitution is chemically similar to that employed with the Boulton and Hunter reagent, and damage might be expected to be related to the number of groups substituted per molecule of IgG. Further refinements to the technique may enable reagents of equally high specific activity to be prepared without measurable effects on affinity, and, once synthesised, DTPA linked antibodies are easy to radiolabel. This has an advantage over iodination for a routine nuclear medicine department.
There have been several suggestions to improve antibody scans, of which increasing the number of counts emanating from the tumour is fundamental.20 Theoretical considerations and our results show that with "'In this is possible because of its physical characteristics and prolonged residence in tumours. This results in improved count rates and improved signal to noise ratios, which allow the detection of smaller or deeper lesions.
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ONE HUNDRED YEARS AGO
The police-courts have lately made public several instances of revolting cruelty suffered by little children in the course of their training for performance as acrobats. It appears that, in the present stage of our civilisation, the supply of acrobats is a steady public demand, and that many British children of very tender years are regularly devoted to the acrobatic business, to be systematically trained, while their limbs and joints are yielding, by a long process of painful exercises enforced by punishment and privation, for the gratification of a debased public taste by their performances as "human serpents," tumblers, and contortionists. Mr Charles Mylne Barker, who acted as honorary solicitor in the proceedings taken some time ago by Mr Littler, QC, and his friends, regarding a number of young English children found living in slavery, or quasi-slavery, at Constantinople, writes to the Times to express his disappointment that a short Act of Parliament has not been passed during the recent session, making it illegal for any infant child of twelve years of age or under to be apprenticed to any trade or business without the consent of a magistrate. Mr Barker states that, with the assistance of the authorities of the Criminal Investigation Department, he had made several inquiries as to the manner in which infant children being trained as acrobats were treated when out of the jurisdiction of English courts; and it was found that, in many instances, the treatment was harsh in the extreme, especially when the children did not take kindly to their calling; and it was believed that a child was actually killed in Spain, its back having been broken by the cruel treatment to which it was subjected. Mr Barker thinks that some philanthropic member of Parliament, at a time when so much public sympathy is expended on the sufferings of pigeons, might have carried through a short Bill such as he has indicated. (British Medical J7ournal 1883 ;ii :440.)
